Double Agent: SPDEF Gene with Both Oncogenic and Tumor-Suppressor Functions in Breast Cancer

Ting Ye,* Jia Feng,* Xue Wan, Dan Xie, Jinbo Liu Department of Laboratory Medicine, The Affiliated Hospital of Southwest Medical University, Sichuan 646000, People’s Republic of China*These authors contributed equally to this workCorrespondence: Jinbo LiuDepartment of Laboratory Medical, T...

Full description

Bibliographic Details
Main Authors: Ye T, Feng J, Wan X, Xie D, Liu J
Format: Article
Language:English
Published: Dove Medical Press 2020-05-01
Series:Cancer Management and Research
Subjects:
Online Access:https://www.dovepress.com/double-agent-spdef-gene-with-both-oncogenic-and-tumor-suppressor-funct-peer-reviewed-article-CMAR
_version_ 1819079175525367808
author Ye T
Feng J
Wan X
Xie D
Liu J
author_facet Ye T
Feng J
Wan X
Xie D
Liu J
author_sort Ye T
collection DOAJ
description Ting Ye,* Jia Feng,* Xue Wan, Dan Xie, Jinbo Liu Department of Laboratory Medicine, The Affiliated Hospital of Southwest Medical University, Sichuan 646000, People’s Republic of China*These authors contributed equally to this workCorrespondence: Jinbo LiuDepartment of Laboratory Medical, The Affiliated Hospital of Southwest Medical University, 25 Taiping Street, Luzhou 646000, Sichuan, People’s Republic of ChinaTel +86830 3165730Email liulab2019@163.comAbstract: The dichotomy of cancer-regulatory genes into “oncogenes (OCGs)” and “tumor-suppressor genes (TSGs)” has greatly helped us in learning molecular details of tumor biology. SPDEF, known as the prostate-derived ETS factor, is reported to play a pivotal role in normal cell development and survival, which has also been endowed with dual characteristics in cancers. Breast cancer (BC) is a highly heterogeneous disease which becomes the leading reason for cancer-related fatality among women worldwide. The involvement of SPDEF in many aspects of BC has been postulated, whereas the mechanism governing the regulation of the pro- and anti-oncogenic activities of SPDEF in BC state remains poorly defined. In this review, we summarized SPDEF as the double agent involving in expression profiles, the regulatory mechanism in BC progression, as well as the role in diagnosis, treatment and prognosis of BC. The understanding of SPDEF duality has contributed to gain insight into the tumor biology and also add a new dimension to the new therapy targets for BC.Keywords: SPDEF, double agent, oncogenes, tumor-suppressor genes, transcription factor, breast cancer
first_indexed 2024-12-21T19:24:49Z
format Article
id doaj.art-ec0d38b6097349e796397a9565da3009
institution Directory Open Access Journal
issn 1179-1322
language English
last_indexed 2024-12-21T19:24:49Z
publishDate 2020-05-01
publisher Dove Medical Press
record_format Article
series Cancer Management and Research
spelling doaj.art-ec0d38b6097349e796397a9565da30092022-12-21T18:52:52ZengDove Medical PressCancer Management and Research1179-13222020-05-01Volume 123891390254041Double Agent: SPDEF Gene with Both Oncogenic and Tumor-Suppressor Functions in Breast CancerYe TFeng JWan XXie DLiu JTing Ye,* Jia Feng,* Xue Wan, Dan Xie, Jinbo Liu Department of Laboratory Medicine, The Affiliated Hospital of Southwest Medical University, Sichuan 646000, People’s Republic of China*These authors contributed equally to this workCorrespondence: Jinbo LiuDepartment of Laboratory Medical, The Affiliated Hospital of Southwest Medical University, 25 Taiping Street, Luzhou 646000, Sichuan, People’s Republic of ChinaTel +86830 3165730Email liulab2019@163.comAbstract: The dichotomy of cancer-regulatory genes into “oncogenes (OCGs)” and “tumor-suppressor genes (TSGs)” has greatly helped us in learning molecular details of tumor biology. SPDEF, known as the prostate-derived ETS factor, is reported to play a pivotal role in normal cell development and survival, which has also been endowed with dual characteristics in cancers. Breast cancer (BC) is a highly heterogeneous disease which becomes the leading reason for cancer-related fatality among women worldwide. The involvement of SPDEF in many aspects of BC has been postulated, whereas the mechanism governing the regulation of the pro- and anti-oncogenic activities of SPDEF in BC state remains poorly defined. In this review, we summarized SPDEF as the double agent involving in expression profiles, the regulatory mechanism in BC progression, as well as the role in diagnosis, treatment and prognosis of BC. The understanding of SPDEF duality has contributed to gain insight into the tumor biology and also add a new dimension to the new therapy targets for BC.Keywords: SPDEF, double agent, oncogenes, tumor-suppressor genes, transcription factor, breast cancerhttps://www.dovepress.com/double-agent-spdef-gene-with-both-oncogenic-and-tumor-suppressor-funct-peer-reviewed-article-CMARspdefdouble agentoncogenestumor-suppressor genestranscription factorbreast cancer
spellingShingle Ye T
Feng J
Wan X
Xie D
Liu J
Double Agent: SPDEF Gene with Both Oncogenic and Tumor-Suppressor Functions in Breast Cancer
Cancer Management and Research
spdef
double agent
oncogenes
tumor-suppressor genes
transcription factor
breast cancer
title Double Agent: SPDEF Gene with Both Oncogenic and Tumor-Suppressor Functions in Breast Cancer
title_full Double Agent: SPDEF Gene with Both Oncogenic and Tumor-Suppressor Functions in Breast Cancer
title_fullStr Double Agent: SPDEF Gene with Both Oncogenic and Tumor-Suppressor Functions in Breast Cancer
title_full_unstemmed Double Agent: SPDEF Gene with Both Oncogenic and Tumor-Suppressor Functions in Breast Cancer
title_short Double Agent: SPDEF Gene with Both Oncogenic and Tumor-Suppressor Functions in Breast Cancer
title_sort double agent spdef gene with both oncogenic and tumor suppressor functions in breast cancer
topic spdef
double agent
oncogenes
tumor-suppressor genes
transcription factor
breast cancer
url https://www.dovepress.com/double-agent-spdef-gene-with-both-oncogenic-and-tumor-suppressor-funct-peer-reviewed-article-CMAR
work_keys_str_mv AT yet doubleagentspdefgenewithbothoncogenicandtumorsuppressorfunctionsinbreastcancer
AT fengj doubleagentspdefgenewithbothoncogenicandtumorsuppressorfunctionsinbreastcancer
AT wanx doubleagentspdefgenewithbothoncogenicandtumorsuppressorfunctionsinbreastcancer
AT xied doubleagentspdefgenewithbothoncogenicandtumorsuppressorfunctionsinbreastcancer
AT liuj doubleagentspdefgenewithbothoncogenicandtumorsuppressorfunctionsinbreastcancer